LOG IN
SIGN UP
MARKET
ASXC
ASXC
Asensus Surgical Inc
AMEX
Real-time Quotes | Nasdaq Last Sale
0.3823
-0.0158
-3.97%
Opening 15:49 07/01 EDT
OPEN
0.3949
PREV CLOSE
0.3981
HIGH
0.4086
LOW
0.3800
VOLUME
1.70M
TURNOVER
381.95K
52 WEEK HIGH
3.190
52 WEEK LOW
0.3500
MARKET CAP
90.40M
P/E (TTM)
-1.3968
1D
5D
1M
3M
1Y
5Y
Asensus Surgical to Showcase the Senhance Surgical System and Performance-Guided Surgery in Upcoming Society of Robotic and Digital Surgery Conference
RESEARCH TRIANGLE PARK, N.C., June 28, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™,...
GlobeNewswire · 3d ago
Inovio Pharma, Bionano Genomics among health care stocks to join Russell Microcap Index; Tonix Pharma, iBio to leave
FTSE Russell has released a preliminary lists of companies set to join or leave the Russell Microcap Index as part of its 2022 annual reconstitution. Notable health care additions include: Inovio Pharma
Seekingalpha · 06/06 15:59
Clover Health, Aurinia Pharma among the top 10 health care additions to Russell 3000 Index, Asensus Surgical, Clovis Oncology among top deletions
At 2022 Russell indexes annual reconstitution, following notable health care stocks will be added to and deleted from the Russell 3000 Index. Notable additions: Clover Health Investments (CLOV), Aurinia Pharmaceuticals (AUPH), Nano-X Imaging
Seekingalpha · 06/06 15:39
Triangle market caps keep tanking – Duke economist explains the volatility
The public markets plunge continues, with a Raleigh technology firm’s market cap tanking 82 percent year-over-year – just one of many firms feeling the pressure. A review of market cap data conducted by the Business Journals shows virtually all Triangle p...
American City Business Journals · 05/24 12:04
Asensus Surgical's Return On Capital Employed Insights
Benzinga Pro data, Asensus Surgical (AMEX:ASXC) reported Q1 sales of $1.07 million. Earnings fell to a loss of $19.13 million, resulting in a 20.45% decrease from last quarter.
Benzinga · 05/23 14:45
Asensus Surgical to Participate in the H. C. Wainwright Global Investment Conference
RESEARCH TRIANGLE PARK, N.C., May 11, 2022--Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the H. C. Wainwright Global Investment Conference in ...
Business Wire · 05/11 10:55
Asensus Surgical down 4% post market following quarterly top line miss
Shares of Asensus Surgical (NYSE:ASXC) fell 4% in after-hours trading after reporting Q1 2022 revenue that fell below consensus estimates. Net loss widened ~10% year over year to $19.1M, but still beat
Seekingalpha · 05/04 21:38
BRIEF-Asensus Surgical, Inc. Reports Q1 Results
reuters.com · 05/04 21:23
No Data
Learn about the latest financial forecast of ASXC. Analyze the recent business situations of Asensus Surgical Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating
Based on 1 analysts
Buy
Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.
0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average ASXC stock price target is 4.000 with a high estimate of 4.000 and a low estimate of 4.000.
Current 0.3886
EPS
Actual
Estimate
-0.06-0.05-0.03-0.02
Institutional Holdings
Institutions: 157
Institutional Holdings: 73.36M
% Owned: 31.03%
Shares Outstanding: 236.46M
TypeInstitutionsShares
Increased
45
6.91M
New
19
2.21M
Decreased
31
11.32M
Sold Out
24
1.40M
- Performance
- Asset Allocation
- Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+2.10%
Healthcare Equipment & Supplies
+1.91%
Key Executives
Non-Executive Chairman/Independent Director
David Milne
President/Chief Executive Officer/Director
Anthony Fernando
Chief Financial Officer/Executive Vice President
Shameze Rampertab
Independent Director
Andrea Biffi
Independent Director
Kevin Hobert
Independent Director
Elizabeth Kwo
Independent Director
Richard Pfenniger
Independent Director
William Starling
No Data
No Data
About ASXC
Asensus Surgical, Inc. is a medical device company that is digitizing the interface between the surgeon and the patient through Performance-Guided Surgery. The Company is focused on the market development and commercialization of the Senhance Surgical System, which digitizes laparoscopic minimally invasive surgery (MIS). The Senhance System is a digital and multi-port laparoscopic platform designed to maintain laparoscopic MIS standards while providing digital benefits, such as haptic feedback, robotic precision, comfortable ergonomics, advanced instrumentation, including three-millimeter (mm) micro laparoscopic instruments, five mm articulating instruments, eye-sensing camera control and fully reusable standard instruments to patients around the world. Its Senhance System is used in Europe for adult and pediatric laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations. It is also available in the United States, Japan, Taiwan and Russia.
Webull offers kinds of Asensus Surgical Inc stock information, including AMEX:ASXC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASXC stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading ASXC stock methods without spending real money on the virtual paper trading platform.